Related references
Note: Only part of the references are listed.PROTACs: A novel strategy for cancer therapy
Jing Liu et al.
SEMINARS IN CANCER BIOLOGY (2020)
Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects
Vicky Hakim-Eshed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Excess of the NF-κB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1-and chemokines-mediated mechanisms
Yelena Kravtsova-Ivantsiv et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Development of Stabilized Peptide-Based PROTACs against Estrogen Receptor alpha
Yanhong Jiang et al.
ACS CHEMICAL BIOLOGY (2018)
NFKB1: a suppressor of inflammation, ageing and cancer
Tyrell Cartwright et al.
FEBS JOURNAL (2016)
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer
Ohad Tarcic et al.
CELL REPORTS (2016)
KPC1-Mediated Ubiquitination and Proteasomal Processing of NF-κB1 p105 to p50 Restricts Tumor Growth
Yelena Kravtsova-Ivantsiv et al.
CELL (2015)
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor
D. J. Voce et al.
ONCOGENE (2015)
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination during Proteasomal Degradation
Alexey Belogurov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2007)
IKKα controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression
Gueter Schneider et al.
EMBO JOURNAL (2006)
Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase
S Kotoshiba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression
S Shukla et al.
NEOPLASIA (2004)
Share Paper
